Scinai Immunotherapeutics Ltd. (SCNI) Form 8-K Material Events
Scinai Immunotherapeutics Ltd. (SCNI) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SCNI
CIK: 1611747
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ziv Haft Certified Public Accountants (Isr.)
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerOmer Margalit
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-16 | 2026-10-16 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-110069 | View SEC Doc Filr Page |
| 6-K | 2026-10-15 | 2026-10-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-109633 | View SEC Doc Filr Page |
| 6-K | 2026-10-13 | 2026-10-13 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-108730 | View SEC Doc Filr Page |
| EFFECT | 2026-10-05 | — | EFFECT Filing | 9999999995-26-003155 | View SEC Doc Filr Page |
| F-1 | 2026-09-24 | — | REGISTRATION STATEMENT | 0001213900-26-103067 | View SEC Doc Filr Page |
| 6-K | 2026-09-21 | 2026-09-21 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-101636 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-08 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-097891 | View SEC Doc Filr Page |
| EFFECT | 2026-08-28 | — | EFFECT Filing | 9999999995-26-002805 | View SEC Doc Filr Page |
| POS AM | 2026-08-27 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-26-094234 | View SEC Doc Filr Page |
| 6-K | 2026-08-26 | 2026-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-093738 | View SEC Doc Filr Page |
| 6-K | 2026-08-19 | 2026-08-19 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-091445 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-09 | — | SCHEDULE 13G/A Filing | 0002055074-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-01 | — | SCHEDULE 13G/A Filing | 0001948744-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0001178913-26-003261 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0001178913-26-003259 | View SEC Doc Filr Page |
| 6-K | 2026-06-17 | 2026-06-17 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-069407 | View SEC Doc Filr Page |
| 6-K | 2026-06-15 | 2026-06-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-068495 | View SEC Doc Filr Page |
| 6-K | 2026-06-08 | 2026-06-08 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-066166 | View SEC Doc Filr Page |
| EFFECT | 2026-05-19 | — | EFFECT Filing | 9999999995-26-001706 | View SEC Doc Filr Page |
| 424B3 | 2026-05-19 | — | PROSPECTUS | 0001213900-26-058989 | View SEC Doc Filr Page |
| CORRESP | 2026-05-15 | — | CORRESP Filing | 0001213900-26-057419 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-14 | — | UPLOAD Filing | 0000000000-26-004903 | View SEC Doc Filr Page |
| 6-K | 2026-05-12 | 2026-05-12 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-055215 | View SEC Doc Filr Page |
| F-3 | 2026-05-08 | — | REGISTRATION STATEMENT | 0001213900-26-053855 | View SEC Doc Filr Page |
| 6-K | 2026-05-08 | 2025-12-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-053561 | View SEC Doc Filr Page |